Gilead Sciences Inc (GILD)
77.89
+1.68
(+2.20%)
USD |
NASDAQ |
Jun 02, 16:00
75.60
-2.29
(-2.94%)
After-Hours: 06:18
Gilead Sciences Total Return Level: 101.89 for June 2, 2023
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
June 02, 2023 | 101.89 |
June 01, 2023 | 99.70 |
May 31, 2023 | 100.65 |
May 30, 2023 | 99.85 |
May 26, 2023 | 100.85 |
May 25, 2023 | 101.58 |
May 24, 2023 | 103.41 |
May 23, 2023 | 102.80 |
May 22, 2023 | 102.85 |
May 19, 2023 | 103.14 |
May 18, 2023 | 102.31 |
May 17, 2023 | 103.10 |
May 16, 2023 | 102.46 |
May 15, 2023 | 102.53 |
May 12, 2023 | 102.26 |
May 11, 2023 | 102.95 |
May 10, 2023 | 102.18 |
May 09, 2023 | 103.08 |
May 08, 2023 | 102.81 |
May 05, 2023 | 104.33 |
May 04, 2023 | 102.72 |
May 03, 2023 | 103.93 |
May 02, 2023 | 105.23 |
May 01, 2023 | 106.51 |
April 28, 2023 | 107.54 |
Date | Value |
---|---|
April 27, 2023 | 109.30 |
April 26, 2023 | 109.55 |
April 25, 2023 | 111.97 |
April 24, 2023 | 113.42 |
April 21, 2023 | 113.25 |
April 20, 2023 | 110.79 |
April 19, 2023 | 110.03 |
April 18, 2023 | 109.60 |
April 17, 2023 | 109.40 |
April 14, 2023 | 108.58 |
April 13, 2023 | 108.93 |
April 12, 2023 | 107.48 |
April 11, 2023 | 107.98 |
April 10, 2023 | 108.05 |
April 06, 2023 | 109.06 |
April 05, 2023 | 109.43 |
April 04, 2023 | 107.43 |
April 03, 2023 | 108.89 |
March 31, 2023 | 108.54 |
March 30, 2023 | 106.55 |
March 29, 2023 | 106.34 |
March 28, 2023 | 105.92 |
March 27, 2023 | 104.10 |
March 24, 2023 | 104.65 |
March 23, 2023 | 103.03 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
66.55
Minimum
Dec 24 2018
115.00
Maximum
Dec 08 2022
82.11
Average
79.27
Median
Total Return Level Benchmarks
Johnson & Johnson | 492.79 |
Pfizer Inc | 125.94 |
AbbVie Inc | 210.15 |
Merck & Co Inc | 367.94 |
Bristol-Myers Squibb Co | 251.90 |